VINCENT RICHARD G 4
4 · Oncternal Therapeutics, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
VINCENT RICHARD G
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-04-13$0.30/sh+30,000$8,961→ 156,859 total
Holdings
- 4,526(indirect: By Trust)
Common Stock
- 1,834(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.2975 to $0.3000. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.